IMPORTANT: Updated Interim Clinical Considerations for use of COVID-19 Vaccines Currently Authorized in the United States

Dear Immunization Partners,

Please share the following information with staff and colleagues.

The Centers for Disease Control and Prevention (CDC) has updated the Interim Clinical Considerations for use of COVID-19 Vaccines Currently Authorized in the United States. Updated reference materials can be accessed at the links below.

• Interim COVID-19 Immunization Schedule Updated 5/31/2023 to include corrections in the Moderna and Novavax sections
• FAQs for the Interim Clinical Considerations Updated 6/14/2023 to include specific guidance on when to use the Moderna pink cap formulation
• COVID-19 Vaccination Recommendations Infographic Updated 5/16/2023 added a footnote addressing intervals in Table 1
• COVID-19 Vaccination Recommendations Infographic (Immunocompromised) Updated 5/16/2023 added footnote addressing intervals in Table 2
• COVID-19 Vaccine Product Information Updated 5/16/2023
• Bivalent Moderna COVID-19 Vaccine: When to use the pink versus blue-capped vial Updated 6/12/2023 New infographic explicitly detailing when to use the Moderna pink vs blue capped vial

CDC recommends that everyone ages 6 months and older stay up to date with the COVID-19 vaccine to prevent infection.

Thank you for all you do,

Oakland County Health Division, Immunization Acton Plan